Showing Results for: “diabetes”

“Access to affordable diabetes medications and technology can help people living with diabetes stay healthy and avoid complications. Sadly, some of the 37.3 million Americans living with diabetes can’t afford the treatments they need to survive,” said Charles “Chuck” Henderson, chief executive officer of the American Diabetes Association ® (ADA). “The ADA has been the leading voice in advocating for affordable insulin and diabetes technology. We applaud Amazon Pharmacy for innovating on behalf of people with diabetes and taking important action to help ensure they easily access the treatments

New study points to diabetes management as critical factor in improving patient outcomes during pandemic outbreaks Findings of a new study show diabetes was the main risk factor for the accelerated advancement to a severe state in Japanese COVID-19 patients. Results of the retrospective analysis were presented at the virtual 81st Scientific Sessions of the American Diabetes Association ® (ADA). Throughout the pandemic, diabetes has persisted as a significant risk factor for COVID-19. In hospitalized patients with diabetes and COVID-19, one in 10 people die within seven days of admission

New Platform will Empower the 30 Million Americans with Diabetes to Advocate for Legislation that Promotes Insulin and Drug Affordability The American Diabetes Association (ADA) has created a free Communications & Engagement Platform to demystify the political rhetoric of drug pricing policy for the diabetes community. In keeping with ADA’s commitment to help those living with diabetes thrive, this platform will enable people with diabetes, their families and their health care providers to easily understand the legislative options on the table using three simple questions. It is critical that

First-of-Its-Kind Study Shows Fenofibrate Reduces Eye Disease Progression by 27% Today, findings from the Lowering Events in Non-proliferative retinopathy in Scotland (LENS) Trial revealed that fenofibrate, a medication used for many years to reduce blood fat levels, significantly reduces the progression of diabetic retinopathy, a diabetes-related eye disease. Delivered by Oxford Population Health, this is the first large-scale trial specifically designed to investigate the effect of this drug on eye outcomes in people with early diabetic retinopathy. The results were presented at a symposium

The American Diabetes Association® applauds Connecticut’s governor and legislature for passing a cap on co-pays for diabetes medications and supplies Recently, Connecticut House Bill 6003 was signed into law by Governor Ned Lamont. The law limits cost sharing for insulin and other diabetes medications to $25 per 30-day supply for those with state-regulated commercial health insurance. The law also caps diabetes devices and supplies at $100 per 30-day supply, allows for someone with an expired prescription to obtain insulin in an emergency, and establishes a workgroup on connecting people in

Highlights Importance of Nutrition Assistance Programs The American Diabetes Association® (ADA) urges Congress to end the government shutdown, enabling the Supplemental Nutrition Assistance Program (SNAP) to support the nutrition of Americans with limited financial resources and assist them in buying groceries. Nearly 42 million Americans receive monthly benefits. A loss of this resource can lead to food insecurity, which increases the risk for type 2 diabetes and makes it harder to manage. Reduction in access to essential nutrition assistance programs would devastate underserved individuals

Cycling event raises funds to support diabetes research, local programming, and advocacy efforts The American Diabetes Association ® (ADA) is thrilled to host the 2025 Tour de Cure ®: North Carolina at Bicentennial Park on Saturday, May 17. This cycling event raises funds so the ADA can fight for all people living with diabetes—one of the fastest growing chronic diseases in the world.  Nationwide, over 38 million people have diabetes, and every 26 seconds, someone new is diagnosed. Over one million adults in North Carolina, or 10.6% of the adult population, have been diagnosed with diabetes

“The American Diabetes Association ® (ADA) is the leading voice advocating for insulin affordability and is working to ensure that all people with diabetes have access to the care they need. The ADA has led the charge to enact cost-sharing limits on insulin in 22 states and D.C., and now the first-ever federal copay cap in Medicare. We are pleased that more manufacturers are continuing to take steps to make insulin more affordable, and we hope others follow suit. ADA will keep working to make sure drug rebates are not inflating costs for patients at the pharmacy counter, and we will continue

The American Diabetes Association ® applauds the Washington governor and legislature for passing SB 6087 Recently, Washington Governor Jay Inslee signed into law American Diabetes Association (ADA)-supported legislation capping monthly copayments for insulin at $100 for a 30-day supply. Senate Bill 6087 (SB 6087) requires insulin to be covered by state regulated commercial health insurance plans and state employee plans without being subject to a deductible. In addition, any cost sharing the individual is required to pay by their policy will be applied toward their deductible. The bill also

The American Diabetes Association® (ADA) recognizes the release of the new dietary guidelines as an important opportunity to advance health and prevent chronic disease for all Americans. We are encouraged that these new guidelines identify the unique needs of people with chronic metabolic conditions like diabetes. As the nation’s leading organization dedicated to ending diabetes and helping people thrive, the ADA supports evidence-based guidance that promotes practical, accessible, and culturally responsive healthy eating patterns. Ensuring that families and communities can translate food and